+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Emtricitabine"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
From
From
From
Stribild Drug Overview 2019 - Product Thumbnail Image

Stribild Drug Overview 2019

  • Report
  • June 2019
  • 16 Pages
  • Global
Isentress (raltegravir; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Isentress (raltegravir; Merck & Co) Drug Overview 2019

  • Report
  • June 2019
  • 14 Pages
  • Global
From
From
Loading Indicator

Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of immune disorders. It is used in combination with other drugs to treat HIV/AIDS, hepatitis B, and other immune disorders. It works by blocking the action of reverse transcriptase, an enzyme that is essential for the replication of HIV and other viruses. Emtricitabine is also used to prevent the transmission of HIV from mother to child during pregnancy. Emtricitabine is available in both oral and injectable forms. It is generally well tolerated, with few side effects. Common side effects include nausea, headache, and fatigue. Serious side effects are rare, but can include liver damage and allergic reactions. Emtricitabine is marketed by several pharmaceutical companies, including Gilead Sciences, Bristol-Myers Squibb, and Merck. It is also available in generic form from several generic drug manufacturers. Show Less Read more